Teva Pharmaceutical Industries

Bookmark

Add to MyYahoo RSS

Teva Pharmaceutical Industries News

News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.

12 hrs ago | The Motley Fool

3 Reasons Dividend Stock Teva Pharmaceutical Industries Ltd. Could Fall

This rising tide among generic drug manufacturers is due mainly to the ongoing patent cliff, which has opened up a diversity of new opportunities for these companies. Even so, the rapid rise of this group of stocks has in some cases out-paced their underlying fundamentals, especially from a top-line growth perspective.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Financial Markets

18 hrs ago | Sys-Con Media

OncoGenex Announces Completion of Patient Enrollment in the Phase 3...

The international, randomized, open-label Phase 3 AFFINITY trial is designed to evaluate the potential of custirsen to improve survival outcomes in approximately 630 men with metastatic castrate-resistant prostate cancer . Patients have been randomized to receive second-line JevtanaA and prednisone with or without custirsen.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, SONUS Pharmaceuticals, OncoGenex Pharmaceuticals, Healthcare Industry, Prednisone (generic), Deltasone, Orasone, Food and Drug Administration

Mon Sep 15, 2014

Freshnews

Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer

Antares Pharma, Inc. today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. The Company also announced that a retained search has begun to fill the position of Chief Financial Officer.

Comment?

Related Topix: Antares Pharma, Medicine, Medical Equipment, Healthcare Industry, Biotech, Inkine Pharmaceutical, Marketing

Sat Sep 13, 2014

Seeking Alpha

Teva Pharmaceutical Is Poised To Grow

Teva is trying to recover the Copaxone sales loss due to patent expiration by introducing an improved version of Copaxone 40mg. Teva revealed positive data from the phase 3 study of its drug reslizumab for the treatment of moderate to severe asthma.

1 comment

Related Topix: Biotech, Medicine, Asthma, Health, AstraZeneca, AstraZeneca Group, Healthcare Industry, Teva Pharmaceutical Industries, Pharmaceuticals

Thu Sep 11, 2014

Seeking Alpha

Strong Portfolio Will Drive Growth For Mylan

Recently the company launched two products; the first generic version of Upsher-Smith's Klor-Con and the Dexmedetomidine Hydrochloride injection. Its ANDA Glatiramer Acetate injection 40 mg/mL, the generic version of Teva's Copaxone 40 mg/mL, has also been accepted for filing by the FDA.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Dey, Startups, Mylan Laboratories

BioSpace

Teva Pharmaceutical Industries Limited Presents New Data Which...

Teva Pharmaceutical Industries Ltd. today announced new data from the open-label Phase IIIb GLatiramer Acetate low frequenCy safety and patIent ExpeRience study, comparing the safety and tolerability of three-times-a-week COPAXONEA 40 mg to daily COPAXONEA 20 mg in patients with relapsing-remitting multiple sclerosis . During a platform presentation this week, the results from the GLACIER study were shared at the MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting being held in Boston, Massachusetts.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

CFR Solutions is a Dallas-b... Newnote Financial Enters into Strategic Partnership with Net-Cents to Enable Clients to Instantly Convert Crypto Currency to Fiat and Transfer Funds )--Newnote Financial Corp. , is pleased to announce that it has entered into a strategic partnership with ... )--Agiliance today announced that it has earned three 2014 Golden Bridge Business and Innovations Awards.

Comment?

Related Topix: ACT Teleconferencing, Telecom, panels, Biotech

Wed Sep 10, 2014

Hispanic Business

Teva's Reslizumab Delivers Clinically and Statistically Significant...

In both trials, reslizumab treatment showed both clinically relevant and statistically significant reductions in the frequency of CAE compared to placebo . The combination of an effect on clinically important exacerbations and on improvements and preservation of lung function suggest that reslizumab may be a uniquely differentiated treatment for patients with moderate to severe asthma with elevated levels of blood eosinophils.

Comment?

Related Topix: Biotech, Cephalon

Wed Sep 03, 2014

BioSpace

Data To Be Presented At Joint Meeting Underscore Teva Pharmaceutical ...

Teva Pharmaceutical Industries Ltd. today announced that more than 20 company-sponsored abstracts including data on COPAXONEA and laquinimod, an investigational therapy for multiple sclerosis , will be featured at the MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting in Boston, Massachusetts, September 10 - 13, 2014.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

BioSpace

Teva Pharmaceutical Industries Limited Launches SYNCare Home...

Teva Pharmaceutical Industries Ltd. today announced the launch of SYNCareTM, a comprehensive program designed to support patients taking SYNRIBOA for injection, for subcutaneous use, at home.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Food and Drug Administration

Freshnews

Antares Pharma to Participate at the Morgan Stanley Healthcare Conference

Antares Pharma, Inc. today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial Officer and President of the Parenteral Products Group, will participate at the Morgan Stanley Healthcare Conference in New York on Wednesday September 10, 2014 at 8:35 am Eastern Time.

Comment?

Related Topix: Antares Pharma, Medicine, Medical Equipment, Healthcare Industry, Investment Banking, Morgan Stanley European Fund, Financial Services, Morgan Stanley, Biotech

Customer Interaction Solutions

Teva Announces UK High Court Gives Positive Judgment in the Company's Patent Case Against AstraZeneca

Teva Pharmaceutical Industries Ltd., today announced that a positive judgment has been given by the UK High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Foradil, Formoterol (generic), Pulmicort, Budesonide (generic), Marketing, Women's Health, Health

Tue Sep 02, 2014

The Miami Herald

Frost invests in drone maker

Healthcare serial entrepreneur Phillip Frost is leading an $825,000 investment in Drone Aviation Holding Corp., a Jacksonville-based drone development company.

Comment?

Related Topix: Healthcare, Biotech, Opko Health

Theflyonthewall.com

Medtronic, AbbVie reimburse executives for inversion-triggered taxes, WSJ says

Medtronic announces first implants in AdaptResponse CRT clinical trial Medtronic announced the first implants in a clinical trial that will compare patient and healthcare system outcomes in heart failure patients who have cardiac resynchronization therapy devices with the AdaptivCRT feature enabled versus patients receiving standard CRT.

Comment?

Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Drug Enforcement Administration, Biotech, Gilead Sciences

Reuters

Teva finds positive results in advanced trials for asthma drug

Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Cephalon, Pharmaceuticals

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Now through November 4, students in grad... )--Teva Pharmaceutical Industries Ltd. announced today that reslizumab, an investigational anti-IL-5 monoclonal antibody, demonstrated clear levels of efficacy ... )--Today, The Prudential Spirit of Community Awards begins its search for Michigan's top youth volunteers of 2015.

Comment?

Related Topix: Manufacturing, Automakers, Superior Industries International, Washington DC, Biotech

Mon Sep 01, 2014

The Motley Fool

3 Reasons Teva Pharmaceutical Industries Ltd. Stock Could Rise

Generic and specialty drugmakers have been experiencing a profit bonanza as former top-selling products have lost patent protect in recent years.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Thu Aug 28, 2014

TheStreet.com

Teva Dividend Could Be Hurt by Bank of Israel's Rate Cut

TEL AVIV -- The recent decision from Bank of Israel to cut its basic cash rate to a historic low of 0.25% could also bring down the dividend payment to investors in leading Israeli companies such as Teva Pharmaceutical Industries Why? This decision may depreciate the Israeli currency, the New Israeli Shekel, against the U.S. dollar, which will ... (more)

Comment?

Related Topix: Biotech, Financial Markets, Business News

Wed Aug 27, 2014

BioSpace

Teva Pharmaceutical Industries Limited Recalls Parkinson's Disease...

Teva Pharmaceutical Industries just issued a recall of one lot of its generic Parkinson's disease combination medication, carbidopa/levodopa, over it potentially containing too much of an active pharmaceutical ingredient.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Cephalon, Parkinson's Disease, Health

Express India

India's Venus Remedies surges; to collaborate with Teva on drug

Venus will collaborate with Teva Pharmaceutical Industries Ltd to develop an anti-cancer drug, it said in a statement on Tuesday.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••